Health Affairs 03/21/2018
DPL, Commonwealth Fund and Health Affairs Release Policy Papers
Three policy papers released by Health Affairs in collaboration with the Drug Pricing Lab and the Commonwealth Fund cover fundamental prescription drug pricing problems.
Culminating a collaboration with the Drug Pricing Lab and The Commonwealth Fund, Health Affairs has released the final three policy papers that delve into key prescription drug pricing issues. In combination with the companion primer series, the three Policy Options papers address fundamental challenges in the drug pricing landscape and lay out policy proposals presented for each issue. The papers are accessible via the following links:
Improving The Affordability Of Specialty Drugs By Addressing Patients' Out-Of-Pocket Spending
Promoting Competition To Address Pharmaceutical Prices
Policy Strategies For Aligning Price And Value For Brand-Name Pharmaceuticals